Bio-Techne Corp. buy Citigroup Inc.
Start price
21.08.25
/
50%
€46.80
Target price
21.08.26
€60.09
Performance (%)
-4.79%
Price
18.03.26
€44.40
Summary
This prediction is currently active. With a performance of -4.79%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. Dividends of €0.16 are taken into consideration when calculating the performance. This prediction currently runs until 21.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -0.448% | -0.448% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $70.00 price target on the stock, up previously from $55.00.
Ratings data for TECH provided by MarketBeat